Gene therapy could ‘turn off’ severe allergies
A single treatment giving life-long protection from severe allergies such as asthma could be made possible by immunology research at The University of Queensland.
A team led by Associate Professor Ray Steptoe at the UQ Diamantina Institute has been able to ‘turn-off’ the immune response which causes allergic reaction in animals.
“When someone has an allergy or asthma flare-up, the symptoms they experience results from immune cells reacting to protein in the allergen,” Professor Steptoe said.
“The challenge in asthma and allergies is that these immune cells, known as T-cells, develop a form of immune ‘memory’ and become very resistant to treatments.
“We have now been able ‘wipe’ the memory of these T-cells in animals with gene therapy, de-sensitising the immune system so that it tolerates the protein.
“Our work used an experimental asthma allergen, but this research could be applied to treat those who have severe allergies to peanuts, bee venom, shell fish and other substances.”
Dr Steptoe said the findings would be subject to further pre-clinical investigation, with the next step being to replicate results using human cells in the laboratory.”
“We take blood stem cells, insert a gene which regulates the allergen protein and we put that into the recipient.
Associate Professor Ray Steptoe from The University of Queensland on Vimeo.
“Those engineered cells produce new blood cells that express the protein and target specific immune cells, ‘turning off’ the allergic response.”
Dr Steptoe said the eventual goal would be a single injected gene therapy, replacing short-term treatments that target allergy symptoms with varying degrees of effectiveness.
“We haven’t quite got it to the point where it’s as simple as getting a flu jab, so we are working on making it simpler and safer so it could be used across a wide cross-section of affected individuals,” Dr Steptoe said.
“At the moment, the target population might be those individuals who have severe asthma or potentially lethal food allergies.”
Dr Steptoe’s research has been funded by the Asthma Foundation and the National Health and Medical Research Council.
Asthma Foundation of Queensland and New South Wales Chief Executive Officer Dr Peter Anderson said more than two million Australians have asthma, and current statistics show that more than half of those are regularly burdened with symptoms of the disease.
“Even though there are effective treatments available for the vast majority, patients face a number of obstacles and challenges in their self-management practices,” Dr Anderson said.
“The Foundation welcomes the findings of this research and looks forward to a day in the future when a safe one-off treatment may be available that has the potential to eliminate any experience of asthma in vulnerable patients.”
Learn more: Gene therapy could ‘turn off’ severe allergies
[osd_subscribe categories=’allergies’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “ALLERGIES’]
The Latest on: Gene therapy for allergies
[google_news title=”” keyword=”Gene therapy for allergies” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- Gene expression analyses identify potential drivers of chronic allergic inflammation
Currently, most therapies for allergic diseases require lifelong treatment ... to understand the diversity and cellular mechanisms of human Th2 cells. By conducting gene expression analyses of ...
- U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ™ (fidanacogene elaparvovec-dzkt) for the ...
- FDA approves Beqvez gene therapy for adults with hemophilia B
Beqvez is indicated for those on preventive treatment with a factor IX replacement therapy or have had life-threatening bleeding episodes.
- AMR therapy dog ‘Freddie’ ready for National Animal Therapy Day
Ahead of National Animal Therapy Day next week, we’re getting a first-hand look at the unconditional love a furry, four-legged friend can offer in times of trauma and crisis.
- Ditch the Shots, Drop the Allergies: Curex's Telehealth Sublingual Therapy
Co-founders Charles and Gene each have their own journeys of ... The company is striving to ensure that everyone in need of allergy care therapy has access to this potentially life-changing ...
via Google News and Bing News